vendredi 8 janvier 2016

Onco Actu du 8 janvier 2016

2.11 Etiologie - Alimentation

Sugar in Western diets increases risk for breast cancer tumors and metastasis [MD Anderson Cancer Center]

3. Prévention

Special Report on the Future of Cancer Prevention Research Published in American Association for Cancer Research Journal [AACR]

3.1 Tabac

Indian lawmakers, health officials spar over tobacco pack warnings [Reuters]

3.7 Alcool

How do the UK's new alcohol guidelines compare with the rest of the world's? [The Guardian]

Men's recommended weekly alcohol limit cut to 14 units [The Guardian]

4. Dépistage, diagnostic et pronostic

There’s Not Enough Proof That Cancer Screening Works, Researchers Say [TIME]

4.1 Dép., diag. & prono. - Prostate

Why Doctors Shouldn’t Be Punished for Giving Prostate Tests [NY Times]

4.12 Biopsies liquides

Merck and Biocartis partner on new biomarker test for colorectal cancer [Pharmafile]

5. Traitements

Novel cause of ovarian cancer drug resistance identified [Dana-Farber Cancer Institute]

5.12 Immunothérapies

Kite Pharma Expands Its Clinical and Research Partnership With the National Cancer Institute (NCI) for Next-Generation CAR Programs to Treat B-Cell Malignancies [Kite Pharma]

5.2.1 Pharma - Partenariats

MD Anderson and Kymab announce research and development strategic partnership in immuno-oncology [MD Anderson Cancer Center]

Merus and Gustave Roussy Form Strategic Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Immuno‐Oncology Applications [Gustave Roussy]

Dana-Farber Spinout Grabs $73M, Plus Big Roche Deal, To Craft New Class Of Cancer Drugs [Forbes]

5.3 Traitements - FDA, EMA,...

FDA 2015: A Look Back (and Ahead) – Part 3: Food, Tobacco, and Antimicrobial Resistance [FDA Voice]

“Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny [HealthNewsReview]

FDA 2015: A Look Back (and Ahead) – Part 2: Medical Product Safety and Oversight [FDA Voice]

5.5 ASCO

BIND Therapeutics Presents Complete Data on Clinical Activity of BIND-014 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) at the 2016 Genitourinary Cancers Symposium [Bind]

Myriad Advances Prostate and Renal Cancer Molecular Diagnostic Tests at the 2016 ASCO Genitourinary Cancers Symposium [Myriad]

Roche presents updated results for investigational cancer immunotherapy atezolizumab in advanced bladder cancer [Roche]

2016 Symposium Highlights Notable Research Advances in Genitourinary Cancers [ASCO]

Roche says encouraged by cancer drug atezolizumab study [Reuters]

6.1 Observation

Cancer Death Rate Continues Steady Drop [ACS]

US cancer deaths plummet 23% since 1991 – but not all are benefiting equally [The Guardian]

Cancer death rate continues steady drop, thanks to behavior and science [CNN]

6.6 Publications

Publishers to Start Requiring ORCID iDs [ORCID]

Journals to solve ‘John Smith’ common name problem by requiring author IDs [Science]

Prostate cancer paper retracted after investigation can't review original image [Retraction Watch]

Why Some Publishers are Requiring ORCID iDs for Authors: An Interview with Stuart Taylor, The Royal Society [The Scholarly Kitchen]